Case Studies in the Initial Management of a Person with HIV:
A STEP-HIV Initiative
No Longer Available for Credit
Estimated Time to Complete: 1.0 hours
Jointly Provided by
Support for this activity has been made possible through an
educational grant from Gilead Sciences.
Clinical Gap and Educational Need
The cornerstones of the United States plan for ending the HIV epidemic are early diagnosis of HIV infection and the rapid initiation of effective antiretroviral therapy. The initial patient encounter at the time of HIV diagnosis provides a unique opportunity to engage patients in care and decrease the time to viral suppression. Supportive counseling and a focus on treatment can help destigmatize HIV and reframe HIV as a treatable chronic disease. This activity will empower members of the HIV team to care for patients with a new HIV diagnosis.
Through didactics and clinical vignettes, this free interactive CME/CNE-Certified webinar will discuss ways to help patients navigate the challenges of a new HIV diagnosis, as well as review the basics of antiretroviral therapy initiation.
After participating in the activity, learners should be better able to:
- Recognize useful resources to help patients with a new HIV diagnosis
- Describe baseline labs needed for antiretroviral initiation and monitoring
- Identify the recommended initial antiretroviral regimens and when to start them
|William R. Short, MD, MPH, AAHIVS|
Associate Professor of Medicine
Associate Professor of Obstetrics and Gynecology
Perelman School of Medicine
University of Pennsylvania
|Jillian T. Baron, MD, MPH
Assistant Professor of Medicine
Infectious Diseases Division
Perelman School of Medicine
University of Pennsylvania
William R. Short, MD, MPH, AAHIVS is an Associate Professor of Medicine with a secondary appointment as an Associate Professor of Obstetrics and Gynecology at the Perelman School of Medicine, University of Pennsylvania. Dr. Short graduated with his Doctor of Medicine degree from Hahnemann University. Subsequently he completed an internship, residency, and Chief residency in Internal Medicine followed by an Infectious Diseases Fellowship at the MCP/Hahnemann University. Locally, Dr. Short serves as the Associate Director of the Penn AIDS Clinical Trials Unit (ACTU) and maintains two active clinical practices one in the Penn Community Practice and the second in the Helen O. Dickens OB/GYN Clinic, where he is involved in the care of pregnant women living with HIV. Nationally, he serves on the following: Scientific/Clinical Member of the Department of Health and Human Services (DHHS) Panel for Treatment of HIV-infected Pregnant Women and Prevention of Perinatal Transmission; Member of the HIV Primary Care Guideline Panel; Advisor to the Antiretroviral Pregnancy Registry (APR); Vice-chair elect for the American Academy of HIV Medicine (AAHIVM) and finally as a Member of the Taskforce for the Elimination of Perinatal HIV Transmission in the United States and Co-chair of the Preconception Care for women with HIV working group.
Jillian T. Baron, MD, MPH is an Assistant Professor of Medicine at the Perelman School of Medicine in the Infectious Diseases Division of the University of Pennsylvania. Dr. Baron obtained a Medical Degree from Johns Hopkins School of Medicine and a Master’s in Public Health from the Johns Hopkins Bloomberg School of Public Health with a focus on Epidemiology and Biostatistics. She completed residency training in Internal Medicine at Johns Hopkins Hospital and a fellowship in Infectious Diseases at the University of Pennsylvania. She currently sees patients at an HIV/general infectious disease clinic at Penn Presbyterian Medical Center, and provides adult care for HIV infected caregivers of pediatric patients in conjunction with the Children’s Hospital of Philadelphia Special Immunology Clinic. Her research interests include the HIV cascade of care and dynamics of STI transmission in the setting of HIV infection.
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and ACTHIV Institute. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Academy of CME, Inc., designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses
American Academy of CME, Inc., designates this educational activity for 1.0 ANCC contact hours (0.7 Pharmacotherapeutic Contact Hours).
Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.0 contact hours.
American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until December 16, 2021. PAs should only claim credit commensurate with the extent of their participation.
Other members of the care team will receive a certificate of participation.
This activity has been designed to meet the educational needs of the HIV care team, including physicians (both specialists and primary care/family medicine), nurses, nurse practitioners, physician assistants, and pharmacists who are in practice but are newer to HIV medicine or who are in training. Other healthcare providers may also participate.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:
William R. Short, MD, MPH, AAHIVS: Advisory Board for Scientific Information: ViiV Healthcare; Promotional Speakers Bureau: ViiV Healthcare
Jillian T. Baron, MD, MPH: Consultant (spouse): IQVIA
John JD Juchniewicz, MCIS, CHCP, Edward Moylan, RPh, Natalie Kirkwood, RN, BSN, JD: No relevant financial relationships with any commercial interests.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy or ACTHIV Institute . This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
This activity will discuss off-label information.
Instructions on How to Receive Credit
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME/CE credit for your participation, please complete the post-assessment and program evaluation. Your certificate will be available for printing immediately.
This program should be viewed at a resolution of 1024 x 768 or higher using current versions of Microsoft Internet Explorer, Firefox, Chrome or Safari. A high-speed Internet connection is recommended. You must have the Adobe Flash Player installed on your computer in order to view this program. If you do not have the Adobe Flash Player, you can download this free plug-in from Adobe.com.
Contact: For any questions, please contact: [email protected]
© 2020. This CME/CE-certified activity is held as copyrighted © by American Academy of CME and ACTHIV Institute. Through this notice, the Academy and ACTHIV Institute grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).